RecruitingNot ApplicableNCT06797258

FlexHD® Pliable Investigation in Implant-Based Breast Reconstruction

Safety And Effectiveness Of FlexHD® Pliable Acellular Dermal Matrix In Implant-Based Breast Reconstruction

Sponsor

Musculoskeletal Transplant Foundation

Enrollment

259 participants

Start Date

Mar 26, 2025

Study Type

INTERVENTIONAL

Conditions

Implant Based Breast Reconstruction

Summary

Prospective, multi-center, single-arm clinical study in females undergoing immediate implant-based breast reconstruction using a pre-pectoral technique

Eligibility

Sex: FEMALEMin Age: 22 Years

Inclusion Criteria5

Females at least 22 years of age
Scheduled to undergo unilateral or bilateral mastectomy with immediate implant-based, prepectoral breast reconstruction
Willing to provide Informed Consent
Able to return for all required study visits
Must read and understand English language

Exclusion Criteria9

Is of childbearing potential and has a positive pregnancy test within 7 days of study procedure
Has a residual gross tumor at the intended reconstruction site
Has undergone previous breast surgery, such as lumpectomy or breast augmentation, at the site of implantation with the exception of a biopsy
Has undergone previous radiation therapy to the reconstruction site or chest wall, or is scheduled to undergo post-operative radiation therapy at the reconstruction site
Completed chemotherapy within 3 weeks prior to surgery
Has been diagnosed with a comorbid condition determined by the investigator to place the subject at an increased risk of complications
Has a Body Mass Index (BMI) \>35
Has used nicotine products within 1 month of screening
Must not have taken oral corticosteroids for a minimum of 1 month prior to the procedure or have a history of long-term use of systemic oral corticosteroids or anticipate the use during course of the study

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.